Nano-X Imaging (NNOX) Stock Analysis & Winston Score

Nano-X Imaging is an Israeli medical technology company trying to make X-ray and medical imaging cheaper and more widely available. Its main product is the Nanox.ARC, a digital X-ray device built around a new type of X-ray source that the company says can be produced at lower cost than traditional machines. The company targets hospitals, clinics, and imaging centers, particularly in underserved markets that lack access to affordable diagnostic equipment. Nano-X sells or leases its imaging hardware and aims to generate recurring revenue through a "scan-as-a-service" model, where customers pay per scan rather than buying equipment outright. The company also owns Nanox.AI, a software unit that provides AI-powered tools to help radiologists read medical images. Nano-X operates globally but remains very small, with a market cap around $100 million and deeply negative margins, meaning it spends far more than it earns. The central risk is whether the company can achieve regulatory clearances, scale device deployments, and reach profitability before exhausting its capital.